PPT-COPD by the Guidelines Introduction

Role of Spirometry Implementing Changes to the ABCD Grouping in Practice The Refined ABCD Assessment Tool Pharmacologic Treatment Algorithms Instruments to Assess Symptoms Standardized Tools COPD Assessment Test. Some guidelines have been prepared so that they could be incorporated into a permit condition of a development or embodied as a local law The guidelines are designed however to be the basis of assessment and not the last word Many of the guidelines Over time the airways of those suffering from COPD become permanently obstructed or blocked and gradually lose their ability to function COPD is a major cause of disability and death in Canada and throughout the world According to a recent study 15 Medicines . . Andy Cooke . MRPharmS. Assistant Director, . Head of Medicines Management. Medicines optimisation. ‘Helping patients to make the most of medicines’.  .  . £500m. Principles of Medicines Optimisation. Dietetic Intern. Andrews University. Introduction. Patient’s Initials: NM. Primary . Problem . & other . medical conditions: . COPD. , DM, IBS, Pneumonia, IgA . deficiency. Height: 160.02. Weight: 107.2. :. Bulletin 16-02. The . employee worked for an aggregate of 20 years prior to . 1980 in . any of the labor categories noted in Attachment . 1. (. The DEEOIC identified the . labor categories . in Attachment 1 as those with a very high likelihood . Patient Background. Daishi . Hayato. Age 65. Male. Asian American. Retired. Wife and 4 adult children. Father had lung cancer . Primary Diagnosis: . Acute respiratory distress, COPD, peripheral vascular disease with intermittent . Patient may or may not notice symptoms .. Life expectancy for stage 1 people is only slightly less than the normal people. . It is around 17.4 years for a male who is 65 year old. . Patients who continue smoking will have shorter life than who does not smoke or who stop smoking. . Finlay . Royle. Senior Clinical Commissioning Pharmacist. Lambeth CCG. 1. Medicines Optimisation . Key theme: . Quality. , . Safety . and . Medicines . W. aste. 2. Medicines are the most common therapeutic intervention in healthcare, but their use is often . Clinical Trial Evidence. Introduction . Therapeutic Recommendations . Therapeutic Recommendations in Groups B and D . Bronchodilators in Stable COPD. ICS in Stable COPD. COPD . Potential AEs of ICS Treatment. 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical What is COPD?. How to treat COPD?. What is the prognosis?. 19.3% of US Adults Smoke – 2010. CDC, NHIS 2010. 2010 Current Smokers. %. of Smokers. Demographic. % of Smokers. Demographic. 19.3%. US Adults. . . - . S.Mahalakshmi. SCENARIO- . Here is a 76 yrs old elderly male patient hospitalized for 9 days with complaints of breathlessness and cough with expectoration since 3 days.. Chronic Obstructive Pulmonary Disease (COPD): Diagnosis and Management Eective Date: February 22, 2017ScopeThis guideline provides recommendations for the diagnosis and management of adults aged The Wake Health Model. Sharon D. Cornelison RCP, RRT-NPS. COPD Pathway Team. Inpatient Team. Hospitalist, Critical Care Physician, and/or APP. Respiratory Therapist COPD Navigators. Pulmonary Consult Service (MD and/or NP).